These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6800861)

  • 41. Rising quinolone resistance in Neisseria gonorrhoeae isolates from New Delhi.
    Bhalla P; Vidhani S; Reddy BS; Chowdhry S; Mathur MD
    Indian J Med Res; 2002 Mar; 115():113-7. PubMed ID: 12201175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results of treatment of uncomplicated urogenital gonorrhoea with enoxacin compared with ceftriaxone.
    Calderón E; Conde-Glez C; Echaniz G; Arredondo JL; Olvera J; Hirata C; Villafaña M
    Int J Clin Pharmacol Res; 1988; 8(4):247-51. PubMed ID: 3141301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current status of the antibiotic resistance of Neisseria gonorrhoeae].
    Lind I
    Z Hautkr; 1985 Sep; 60(18):1461-71. PubMed ID: 3933201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence of ciprofloxacin resistant Neisseria gonorrhoeae in north India.
    Sethi S; Sharma D; Mehta SD; Singh B; Smriti M; Kumar B; Sharma M
    Indian J Med Res; 2006 May; 123(5):707-10. PubMed ID: 16873916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Increased Neisseria gonorrhoeae quinolone resistance in Amsterdam].
    Peerbooms PG; Spaargaren J; Fennema JS; Cairo I; Coutinho RA
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1899-900. PubMed ID: 11605315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia.
    Kubanova A; Frigo N; Kubanov A; Sidorenko S; Priputnevich T; Vachnina T; Al-Khafaji N; Polevshikova S; Solomka V; Domeika M; Unemo M
    Sex Transm Infect; 2008 Aug; 84(4):285-9. PubMed ID: 18256105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
    Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
    East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Epidemiological and therapeutic study on gonorrheal infection--study on NY-198 (lomefloxacin) single administration therapy. Sapporo Clinical Research Group for STD].
    Kumamoto Y; Henmi I; Tsunekawa T; Sakai S; Hayashi K; Tanda H; Kato S; Tabata S; Yoshio H; Gohro T
    Hinyokika Kiyo; 1990 Aug; 36(8):969-77. PubMed ID: 2122658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gonococcal drug resistance and treatment of gonorrhoea in Nairobi.
    Perine PL; Biddle JW; Nsanze H; D'Costa LJ; Osaba AO; Widy-Wirski R
    East Afr Med J; 1980 Apr; 57(4):238-46. PubMed ID: 6771118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Acrosoxacin (rosoxacin) sensitivity of Neisseria strains].
    Fuzi M
    Orv Hetil; 1984 Apr; 125(17):1005-7. PubMed ID: 6425763
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficacy of azithromycin 1 g single dose in the management of uncomplicated gonorrhoea.
    Waters LJ; Boag FC; Betournay R
    Int J STD AIDS; 2005 Jan; 16(1):84. PubMed ID: 15705283
    [No Abstract]   [Full Text] [Related]  

  • 52. Antimicrobial susceptibility pattern of Neisseria gonorrhoeae in western Austria.
    Allerberger F; Kofler H; Brezinka C; Guggenbichler JP; Dierich MP
    Wien Klin Wochenschr; 1993; 105(12):346-9. PubMed ID: 8333204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ciprofloxacin versus amoxycillin and probenecid in the treatment of uncomplicated gonorrhoea.
    Lassus A; Karppinen L; Ingervo L; Jeskanen L; Reitamo S; Happonen HP; Karkulahti R
    Scand J Infect Dis Suppl; 1989; 60():58-61. PubMed ID: 2502837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of augmentin treatment regimes in gonorrhoea due to penicillinase-producing Neisseria gonorrhoeae: 1981-1987.
    Robinson OP
    J Chemother; 1989 Jul; 1(4 Suppl):890-2. PubMed ID: 16312690
    [No Abstract]   [Full Text] [Related]  

  • 55. Increasing prevalence of penicillinase-producing Neisseria gonorrhoeae and the emergence of high-level, plasmid-mediated tetracycline resistance among gonococcal isolates in The Gambia.
    Adegbola RA; Sabally S; Corrah T; West B; Mabey D
    Trop Med Int Health; 1997 May; 2(5):428-32. PubMed ID: 9217698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda.
    Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D
    J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quinolone derivative, flumequine, as short-term treatment for gonorrhoea.
    Svindland HB; Svarva PL; Maeland JA
    Br J Vener Dis; 1982 Oct; 58(5):317-20. PubMed ID: 6812849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insufficient evaluation of acrosoxacin in treating gonorrhoea.
    Sumathipala AH
    Br J Vener Dis; 1984 Oct; 60(5):349-50. PubMed ID: 6386098
    [No Abstract]   [Full Text] [Related]  

  • 59. A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.
    Notowicz A; Stolz E; van Klingeren B
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():91-4. PubMed ID: 6438048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acrosoxacin resistance in Neisseria gonorrhoeae.
    Macaulay ME
    Lancet; 1982 Jan; 1(8264):171-2. PubMed ID: 6119550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.